A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design

By afschroeder • March 16, 2026

Ji J, Crespi CM, Yee L, Zekster YA, Al-Saleem A, Petersen L, Lee C, Son N, Smith C, Evans T, Tchkonia T, Kirkland JL, Kuchel GA, Cohen HJ, Sedrak MS. A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design. Ther Adv Med Oncol. 2026 Mar 11;18:17588359261424668. doi: 10.1177/17588359261424668. PMID: 41835341; PMCID: PMC12979913.

Tags: breast cancer, chemotherapy, clinical trials, Fellow, Geriatric oncology, Geriatrics, Hematology/Oncology, novel therapiesl phase II trials, Publications, Quality of Life, survivorship, Veterans Administration

Epigenetic insights into extreme longevity in the world’s oldest terrestrial animal, Jonathan

Vaisvil B, Schmitt DP, Jones A, Kapatral V, Ford JM, Taylor ML, Colwell M, Hollins J, Pascucci S, Weissenow K, Rost B, Notin P, Gerlach[...]

Persistence of cardiovascular risk factor changes after the great recession: fixed effects analysis of prospective cohort data from the multi-ethnic study of atherosclerosis

Karlamangla AS, Thomas D, Merkin SS, Moore KA, Watson KE, Seeman TE. Persistence of cardiovascular risk factor changes after the great recession: fixed effects analysis[...]

Values expressed by women veterans initiating treatment for sleep apnea

Carlson GC, Gomez G, Carlson KJ, MacCabe CHG, Gold AI, Erickson AJ, Saldaña K, Kelly MR, Song Y, Zeidler MR, Fung CH, Alessi CA, Washington[...]